Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
O95994
UPID:
AGR2_HUMAN
Alternative names:
HPC8; Secreted cement gland protein XAG-2 homolog
Alternative UPACC:
O95994
Background:
Anterior gradient protein 2 homolog (AGP2), also known as HPC8 and Secreted cement gland protein XAG-2 homolog, plays a crucial role in MUC2 post-transcriptional synthesis and secretion, suggesting its involvement in mucus production by intestinal cells. Additionally, AGP2 functions as a proto-oncogene, facilitating cell migration, differentiation, and growth, while also promoting cell adhesion.
Therapeutic significance:
AGP2's association with recurrent respiratory infections and failure to thrive, due to gene variants, highlights its potential as a target for therapeutic intervention. Understanding the role of AGP2 could open doors to potential therapeutic strategies for treating these conditions.